CORPORATE PRESENTATION EveCannabis.ca TSX-V: EVE November 2018 - PowerPoint PPT Presentation

CORPORATE PRESENTATION EveCannabis.ca TSX-V: EVE November 2018

Disclaimer Caution Concerning Forward Looking Statements IMPORTANT: YOU MUST READ THE FOLLOWING reliance on such future-oriented financial information and financial are not within the control of Eve & Co Incorporated. Actual future results The information contained in this presentation has been prepared by outlooks. Future-oriented financial information and financial outlooks, as may differ materially from historical results or current expectations. 1600978 Ontario Inc., operating as Eve & Co Incorporated (EVE or the with forward-looking information generally, are, without limitation, based “Company”) and contains confidential information pertaining to the on the assumptions and subject to the risks set out below under the These risks, uncertainties and assumptions could adversely affect the heading “Cautionary Note Regarding Forward-Looking Information” . Eve business, operations and assets of the Company. The information outcome and financial effects of the plans and events described herein. & Co Incorporated’s actual annual production, financial position and contained in this presentation (a) is provided as at the date hereof and is In addition, even if the outcome and financial effects of the plans and results of operations may differ materially from management’s current subject to change without notice, (b) does not purport to contain all the events described herein are consistent with the forward-looking expectations and, as a result, the Company’s annual production, income, information that may be necessary or desirable to fully and accurately information contained in this presentation, those results or developments evaluate an investment in the Company, and (c) is not to be considered expenses and net income may differ materially from the profiles provided may not be indicative of results or developments in subsequent periods. as a recommendation by the Company that any person make an in this presentation. Such information is presented for illustrative Although Eve & Co Incorporated has attempted to identify important risks purposes only and may not be an indication of the Company’s actual investment in EVE. An investment in the securities described herein is and factors that could cause actual actions, events or results to differ speculative and involves a number of risks that should be considered by annual production, financial position or results of operations. materially from those described in forward-looking information, there may a prospective investor. be other factors and risks that cause actions, events or results not to be CAUTIONARY NOTE REGARDING FORWARD-LOOKING as anticipated, estimated or intended. Forward-looking information contained in this presentation is based on the Company’s current This presentation is confidential and is being provided to you solely for INFORMATION: your information and may not be reproduced, in whole or in part, in any This presentation includes forward-looking information and forward- estimates, expectations and projections, which the Company believes form or forwarded or further distributed to any other person. Any looking statements within the meaning of Canadian securities laws. are reasonable as of the current date. The Company can give no Statements containing the words “believe”, “expect”, “intend”, “should”, forwarding, distribution or reproduction of this presentation in whole or in assurance that these estimates, expectations and projections will prove “seek”, “anticipate”, “will”, “positioned”, “project”, “risk”, “plan”, “may”, part is unauthorized. By accepting and reviewing this presentation, you to have been correct. You should not place undue reliance on forward- “estimate” or, in each case, their negative and words of similar meaning acknowledge and agree (i) to maintain the confidentiality of this looking information, which is based on the information available as of the presentation and the information contained herein, (ii) to protect such are intended to identify forward-looking information. Forward-looking date of this presentation. Forward-looking information contained in this information in the same manner you protect your own confidential information involves risks and uncertainties including, but not limited to, presentation is as of the date of this presentation and, except as required the Company’s anticipated business strategies, anticipated trends in the information, which shall be at least a reasonable standard of care, and by applicable law, the Company assumes no obligation to update or Company’s business and anticipated market share, that could cause (iii) to not utilize any of the information contained herein except to assist revise them to reflect new events or circumstances. Historical statements with your evaluation of a potential investment in the Company. actual results or events to differ materially from those expressed or should not be taken as a representation that such trends will be implied by the forward-looking information, general business, economic replicated in the future. No statement in this presentation is intended to CAUTIONARY NOTE REGARDING FUTURE-ORIENTED FINANCIAL and competitive uncertainties, regulatory risks including risks related to be nor may be construed as a profit forecast. Additional information the expected timing of EVE’s licenses and expansions, market risks, INFORMATION related to EVE, including risks and uncertainties, can be found on the Company’s SEDAR profile at www.sedar.com. To the extent any forward-looking information in this presentation risks inherent in manufacturing and agricultural operations as well as constitutes “future -oriented financial information” or “financial outlooks” other general risks of the cannabis industry. Such statements are based upon the current beliefs and expectations of the Company’s management within the meaning of applicable Canadian securities laws, such information is being provided to demonstrate the anticipated market and are subject to significant business, social, economic, political, penetration and the reader is cautioned that this information may not be regulatory, competitive and other risks, uncertainties, contingencies and appropriate for any other purpose and the reader should not place undue other factors. Many assumptions are based on factors and events that 2 TSX-V: EVE · EveCannabis.ca

COMPANY SNAPSHOT • • Situated on a 32-acre property EVE & Co is located in Strathroy, Ontario and listed on the TSX-Venture Exchange (EVE) as well as the • Sales strategy focused on direct OTCQB Venture Market (EEVVF) to retailer (recreational market) • and B2B (export and domestic Cultivation license granted July 22, 2016 medicinal markets) • Sale license granted June 21, 2018 • Annual production capacity of • Extraction license granted September 14, 2018 ~10,000 kg increasing to • New flowering room approved December 7, 2018 ~50,000 kg with expansion project • Anticipated approval of 780,000 sq. ft. expansion in Q3 2019 3 TSX-V: EVE · EveCannabis.ca

PRODUCTION AND EXPANSION CURRENT SIZE EXPANSION COMBINED CAPACITY • • • 220,000 sq.ft. existing Estimated completion June 1,000,000 sq. ft. total greenhouse space 2019 greenhouse space • • • 120,000 sq.ft. original with 780,000 sq.ft. expansion ~50,000 kg per year 100,000 sq.ft. new flowering • Increases capacity to room ~4,000 kg per month • Production Capacity: • Construction cost: ~$32 ~800 kg per month million CURRENT FACILITY PHASE 1 PHASE 2 4 TSX-V: EVE · EveCannabis.ca

SALES STRATEGY MEDICINAL MARKET (CANADA) • B2B sales strategy for sale of clones to other LPs • Product to be sold directly to other LPs • Ongoing discussions for long-term RECREATIONAL MARKET (CANADA) supply agreements • Sales will be made directly to authorized retailers • MOU signed with B.C, Ontario, and MEDICINAL MARKET (EXPORT) Newfoundland for distribution • Company has signed a pre-sales • Additionally product to be sold directly to agreement with distributors for other LPs pharmaceutical and other products in Germany • Sales starting at approximately 100 kg per month, ramping to 300 kg per month after year 1 5 TSX-V: EVE · EveCannabis.ca

SALES STRATEGY The first and only Eve is building Licensed Producer in inroads to access Canada to offer quality the lucrative clone plants to the German Cannabis recreational market in market through Newfoundland Labrador established German operators and through partnerships with new applicants BC NL ON Eve will be balancing brand awareness with pricing when selling Cannabis in the two largest addressable markets: B.C. and Ontario. MOU / LOI 6 TSX-V: EVE · EveCannabis.ca

SALES STRATEGY Eve will be offering multi-serve flower in various sizes in addition to pre-rolled products A fully automated packaging system will maintain high quality control and reduce costs First Licensed Producer to ship clones directly to consumers for the Canadian recreational market. 7 TSX-V: EVE · EveCannabis.ca

OPERATIONS CLONES VEGETATIVE FLOWERING ROOM 8 TSX-V: EVE · EveCannabis.ca